enVVeno Medical Corp logo

enVVeno Medical Corp - Warrants (30/05/2023

(Warrants)
NAS:NVNOW (USA)   Warrants (30/05/2023)
$ 0.01 0 (0%) 09:42 AM EST
At Loss
P/B:
1.53
Volume:
24.25K
Avg Vol (2M):
-
Also Trade In:
Volume:
24.25K
At Loss
Avg Vol (2M):
-
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for enVVeno Medical Corp ( ) from 2018 to Jun 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. enVVeno Medical stock (NVNOW) PE ratio as of Jun 13 2024 is 0. More Details

enVVeno Medical Corp (NVNOW) PE Ratio (TTM) Chart

To

enVVeno Medical Corp (NVNOW) PE Ratio (TTM) Historical Data

Total 0
  • 1
enVVeno Medical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

enVVeno Medical Corp (NVNOW) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

enVVeno Medical Corp logo
enVVeno Medical Corp
NAICS : 339113 SIC : 3841

Share Class Description:

NVNOW: Warrants (30/05/2023)
Description
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).